IL-6 promotes tumorigenesis by altering DNA methylation in cancer cells, by inducing both the expression of DNMT1 [238] and its nuclear translocation through phosphorylation of its NLS via PI-3K/AKT signaling [239]. The gene discussed is DNMT1; the disease is cancer.